Increasing RD activities in pharmaceutical industry is driving revenue growth of the in vivo toxicology market
The global in vivo toxicology market size is expected to reach USD 7.7 billion by 2028 at a CAGR of 5.4%, according to the latest report by Reports and Data. Increasing research and development activities in pharmaceutical industry, fast innovations in animal models, and rising demand for personalized medicine are primary factors fueling revenue growth of the market.
In-vivo toxicology testing refers to the use of various living organisms for finding out the presence of carcinogenic/toxic chemicals in new substances and the effect of these new substances on humans. These tests can also be performed to confirm the absence of toxic substances or chemicals from drug candidates. Therefore, in-vivo testing has become prevalent in the pre-clinical trials.
Growing demand for novel therapeutics has resulted in increased RD activities to search for advanced vaccines or drugs. In addition, animal testing is mandatory for determining toxicology profiles, especially for new drugs. These factors are predicted to augment the demand for in-vivo toxicology testing products, propelling the revenue growth of the market going ahead. Furthermore, rapid technical advances in various animal models are also contributing to the revenue growth of the in-vivo toxicology testing market.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/4022
The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.
The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.
Key companies profiled in the report include:
Jackson Laboratory (U.S.), Charles River Laboratories (U.S.), Envigo (U.S.), JANVIER LABS (France), Taconic Biosciences, Inc. (U.S.), Thermo Fisher Scientific (U.S.), Waters Corporation (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), and PerkinElmer (U.S.).
Market Segmentation by Types:
Product Outlook (Revenue, USD Billion, 2018 - 2028)
- Instruments
- Consumables
- Reagents Kits
- Animal Models
- Mice Models
- Rat Models
- Other Animal Models (Guinea Pigs, Hamsters, Rabbits, and Human Primates)
Test Type Outlook (Revenue, USD Billion, 2018 - 2028)
- Acute
- Sub-acute
- Sub-chronic
- Chronic test type
Testing Facility Outlook (Revenue, USD Billion, 2018 - 2028)
- Outsourced testing facility
- In-house testing facility
Toxicity End Point Outlook (Revenue, USD Billion, 2018 – 2028)
- Immunotoxicity
- Systemic toxicity
- Carcinogenicity
- Genotoxicity
- Developmental reproductive toxicity (DART)
- Other toxicity endpoints
End User Outlook (Revenue, USD Billion, 2018 – 2028)
- Academic and Research Institutes
- Pharmaceutical Biotechnology Companies
- Contract Research Organizations
- Other End Users
Order this Report @ https://www.reportsanddata.com/report-pricing/4022
Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global In Vivo Toxicology market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Further key findings in the report
- In March 2019, the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the U.S. Department of Health and Human Services, declared funding for projects for conducting detailed characterization, direct comparisons, along with further development of Humanized Immune System (HIS) mouse models.
- The animal models segment is predicted to register the highest revenue share in the market going ahead. This segment includes various animals including rats, mice, primates and cattle, etc. Increasing clinical trials combined with the growing advancements in animal models are fueling the segment revenue growth.
- North American market is expected to account for largest revenue share in the global market during the forecast period. This high revenue share is attributed to presence of prominent players operating in the regional market, rising biomedical research in the U.S., and growing preclinical activities by pharmaceutical companies and CROs in North America.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4022
Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
